全球制药

环球制药公司

成长计划的实现

科特 was hired by a 全球制药 company to accelerate their speed to market. After several tepid product launches, the U.S.-based division of this large Japanese drug company with 2500 employees and $2 billion in annual revenue were forecasting a $150MM shortfall with the imminent loss of patent exclusivity on a number of key brands. However, if they could increase their speed to marketing on two key products faster than competitors, they stood to significantly increase revenues, profits, and customer satisfaction.

科特’的方法注入了敏捷性,领导力和灵活性。加快上市速度的目标很明确–以前所未有的制药公司的方式,加速利用药物投放市场的系统的形成。我们共同开发了一种不同的运营方式,彻底改变了新药投放市场的方式,揭开了一些必不可少的合规流程的神秘面纱。出现了新的合作方式。人们得到了发展–经过深思熟虑。由于无利可图的活动和产品被清除,允许测试大胆的想法。围绕加快上市速度而建立这种新的力量,为他们成为该行业中最受客户尊敬和盈利的公司铺平了道路。

66%

organizational growth since beginning work with 科特

55%

在我们任职期间提高盈利能力

2015

员工敬业度急剧上升之后,本年度被《福布斯》评为“最佳工作场所”

121%

预计亏损时达到的年度收入计划的百分比

Through our work with 科特, we have come to understand the importance of collaboration and commitment to accelerate the rate of change. We have seen the tangible benefits within our company, as well as many other organizations.

员工视角 /全球制药公司